161 related articles for article (PubMed ID: 35716119)
1. Demethylzeylasteral reduces the level of proteinuria in diabetic nephropathy: Screening of network pharmacology and verification by animal experiment.
Xu L; Zhao B; Yang L; Dong X; Yang X; Mao Y
Pharmacol Res Perspect; 2022 Aug; 10(4):e00976. PubMed ID: 35716119
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR.
Xiong C; Li L; Bo W; Chen H; XiaoWei L; Hongbao L; Peng Z
J Formos Med Assoc; 2020 Mar; 119(3):685-692. PubMed ID: 31801679
[TBL] [Abstract][Full Text] [Related]
3. Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial.
Ge Y; Xie H; Li S; Jin B; Hou J; Zhang H; Shi M; Liu Z
J Transl Med; 2013 May; 11():134. PubMed ID: 23725518
[TBL] [Abstract][Full Text] [Related]
4. The effects of
Cheng Y; Liu Y; Lin L; Li D; Peng L; Zheng K; Tao J; Li M
Ren Fail; 2024 Dec; 46(1):2295425. PubMed ID: 38178377
[TBL] [Abstract][Full Text] [Related]
5.
Lengnan X; Ban Z; Haitao W; Lili L; Aiqun C; Huan W; Ping Z; Yonghui M
Biomed Res Int; 2020; 2020():9181037. PubMed ID: 32596393
[TBL] [Abstract][Full Text] [Related]
6. The Active Compounds and Therapeutic Target of
Liu P; Zhang J; Wang Y; Shen Z; Wang C; Chen DQ; Qiu X
Front Med (Lausanne); 2021; 8():747922. PubMed ID: 34621768
[No Abstract] [Full Text] [Related]
7. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease.
Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y
J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Tripterygium wilfordii Hook F on animal model of Diabetic Kidney Diseases: A systematic review and meta-analysis.
Jin D; Yu M; Li X; Wang X
J Ethnopharmacol; 2021 Dec; 281():114536. PubMed ID: 34419607
[TBL] [Abstract][Full Text] [Related]
9. Study on toxicity/efficacy related substances and metabolic mechanism of Tripterygium wilfordii Hook. f based on O2LPS correlation analysis.
Song L; Wang J; Nie J; Zhang Y; Han R; Liu H; Ma N; Yang Z; Li Y
J Ethnopharmacol; 2024 Jan; 318(Pt B):116949. PubMed ID: 37506782
[TBL] [Abstract][Full Text] [Related]
10. Combined multi-omics and network pharmacology approach reveals the role of Tripterygium Wilfordii Hook F in treating HIV immunological non-responders.
Liu X; Lin L; Lv T; Lu L; Li X; Han Y; Qiu Z; Li X; Li Y; Song X; Cao W; Li T
Phytomedicine; 2022 Jul; 101():154103. PubMed ID: 35468451
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Pharmacological Mechanisms of
Huang B; Huang C; Zhu L; Xie L; Wang Y; Zhu N
Biomed Res Int; 2021; 2021():5575621. PubMed ID: 34435046
[TBL] [Abstract][Full Text] [Related]
12. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
13. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
Ma RX; Zhao N; Zhang W
Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
[TBL] [Abstract][Full Text] [Related]
14. Based on Network Pharmacology Tools to Investigate the Mechanism of
Xia M; Liu D; Liu H; Zhao J; Tang C; Chen G; Liu Y; Liu H
Front Med (Lausanne); 2021; 8():794962. PubMed ID: 34977095
[No Abstract] [Full Text] [Related]
15. The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification.
Niu H; Fan L; Zhao L; Yao R; He X; Lu B; Pang Z
J Ethnopharmacol; 2022 Jul; 293():115283. PubMed ID: 35427726
[TBL] [Abstract][Full Text] [Related]
16. Prediction of the Potential Mechanism of Triptolide in Improving Diabetic Nephropathy by Utilizing A Network Pharmacology and Molecular Docking Approach.
An X; Fan D; Yin Z; Zhang J; Zhou Y; Tian R; Yan M
Front Biosci (Landmark Ed); 2022 Mar; 27(3):94. PubMed ID: 35345326
[TBL] [Abstract][Full Text] [Related]
17. Combination of mulberry leaf active components possessed synergetic effect on SD rats with diabetic nephropathy by mediating metabolism, Wnt/β-catenin and TGF-β/Smads signaling pathway.
Ji T; Wang J; Xu Z; Cai HD; Su SL; Peng X; Ruan HS
J Ethnopharmacol; 2022 Jun; 292():115026. PubMed ID: 35074452
[TBL] [Abstract][Full Text] [Related]
18. Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.
Jin D; Liu F; Yu M; Zhao Y; Yan G; Xue J; Sun Y; Zhao D; Li X; Qi W; Wang X
J Ethnopharmacol; 2022 Jul; 293():115246. PubMed ID: 35398500
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanism of ovarian toxicity of Hook.F. a study based on network pharmacology and molecular docking.
Wang Z; Gong C; Li Z
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 51(1):62-72. PubMed ID: 35576115
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of Huang-Lian-Jie-Du Decoction on diabetic nephropathy through regulating AGEs/RAGE/Akt/Nrf2 pathway and metabolic profiling in db/db mice.
Tang D; He WJ; Zhang ZT; Shi JJ; Wang X; Gu WT; Chen ZQ; Xu YH; Chen YB; Wang SM
Phytomedicine; 2022 Jan; 95():153777. PubMed ID: 34815154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
